Sarcoma Immunology and Immunotherapy
- 1st Edition - April 1, 2027
- Latest edition
- Editor: Joseph Crompton
- Language: English
Sarcoma Immunology and Immunotherapy offers a timely and comprehensive review of the rapidly evolving field of sarcoma immunology and immunotherapy. This book serves as an essent… Read more
End of Summer Sale
Save up to 30% off
Bright savings for research, study, and discovery
Description
Description
Sarcoma Immunology and Immunotherapy offers a timely and comprehensive review of the rapidly evolving field of sarcoma immunology and immunotherapy. This book serves as an essential resource for healthcare professionals, scientists, and patients, providing insights into the immunologic features of sarcoma and the latest immune-based treatments. Focussing on the recent advances, the book discusses the sarcoma microenvironment and the development of innovative immunotherapies tailored for sarcoma patients. Readers will benefit from a thorough overview of existing knowledge, encompassing foundational concepts in sarcoma immunology, a detailed examination of laboratory research, and a complete summary of ongoing immunotherapy trials. This holistic approach ensures a robust understanding of the current landscape in sarcoma research and treatment. By equipping readers with essential background information and comprehensive reviews, this book fosters a deeper understanding of sarcoma immunology and therapeutic strategies. It empowers healthcare professionals and scientists to stay abreast of critical studies, ultimately enhancing patient care and outcomes in this challenging field.
Key features
Key features
- Offers sufficient background to help readers understand the fundamental concepts of sarcoma immunology, ensuring a solid grasp of the subject
- Delivers a comprehensive overview of laboratory research on sarcoma immunology, highlighting recent discoveries and advancements in the field
- Presents a full overview of sarcoma immunotherapy trials and emerging directions, keeping readers informed about the latest therapeutic developments and clinical applications
Readership
Readership
Oncologists, immunologists, and other medical practitioners who are involved in the diagnosis and treatment of sarcoma patients
Table of contents
Table of contents
PART I: Sarcoma Immunology
1. Introduction to Sarcomas
2. The Tumor Microenvironment (TME) in Sarcomas
3. Natural Killer Cells
4. Dendritic Cells
5. B Cells
6. T Cells
7. Myeloid Cells
PART II: Sarcoma Immunotherapy
8. Checkpoint Inhibitors
9. Cell-Based Immunotherapy (CAR, TCR, TIL)
10. Cytokines, Oncolytic Viruses, and Vaccines
11. Immunotherapy Resistance in Sarcomas
12. Emerging New Therapies and Approaches in Sarcoma Immunotherapy - Challenges
13. Clinical Trials and Future Perspectives
14. Conclusions and Future Directives
1. Introduction to Sarcomas
2. The Tumor Microenvironment (TME) in Sarcomas
3. Natural Killer Cells
4. Dendritic Cells
5. B Cells
6. T Cells
7. Myeloid Cells
PART II: Sarcoma Immunotherapy
8. Checkpoint Inhibitors
9. Cell-Based Immunotherapy (CAR, TCR, TIL)
10. Cytokines, Oncolytic Viruses, and Vaccines
11. Immunotherapy Resistance in Sarcomas
12. Emerging New Therapies and Approaches in Sarcoma Immunotherapy - Challenges
13. Clinical Trials and Future Perspectives
14. Conclusions and Future Directives
Product details
Product details
- Edition: 1
- Latest edition
- Published: April 1, 2027
- Language: English
About the editor
About the editor
JC
Joseph Crompton
Dr. Joseph G. Crompton is a surgeon-scientist with a primary clinical focus on the multi-modality treatment of melanoma and soft tissue sarcoma. His current research interests include characterizing the immune response to cancer and developing novel immunotherapies to treat advanced disease.
Affiliations and expertise
UCLA, USA